Oncorus

Oncorus is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 51-200

Detailed Oncorus Information

Geographic Data

Oncorus headquarters map

Address: 50 Hampshire Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$20M

Raised Total:

$218M

Metrics

3,503,052Website Global Rank

4,037Website Monthly Traffic

Twitter Followers

Description

Oncorus is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.

Contact Phone:
+18573206400

Contact Email:

Oncorus went public on 10/1/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/1/2020

IPO Valuation:
$328M

Ticker Symbol:
ONCR

IPO Price:
$15/share

Amount Raised:
$87M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2016 Series A 1 $5M Astellas Venture Management
Astellas Venture Management
7/2016 Series A 7 $57M MPM Capital
SunStates Fund
Long March Investment Fund
Excelyrate Capital
Deepfield
Celgene
Arkin Bio Ventures
MPM Capital
8/2019 Series B $0 Arkin Bio Ventures
Cowen Healthcare Investments
Perceptive Advisors
Celgene
Deerfield
Sphera Funds Management
Shinhan Private Equity
SV Investment Partners
UTC Investment Co.
Cowen Healthcare Investments
Perceptive Advisors
Astellas Venture Management
IMM Investment
MPM Capital
QUAD Investment Management
Surveyor Capital
UBS Oncology Impact Fund
Arkin Bio Ventures
Cowen Healthcare Investments
Perceptive Advisors
Celgene
Deerfield
Sphera Funds Management
Shinhan Private Equity
SV Investment Partners
UTC Investment Co.
Cowen Healthcare Investments
Perceptive Advisors
Astellas Venture Management
IMM Investment
MPM Capital
QUAD Investment Management
Surveyor Capital
UBS Oncology Impact Fund
2/2021 Post-IPO Equity $57M
4/2022 Post-IPO Debt 1 $20M K2 HealthVentures
K2 HealthVentures
10/2020 IPO $87M
12/2016 Series A $4M Astellas Venture Management LLC
MPM Capital
Deerfield Management
Celgene, Inc
12/2019 Series B $10M
8/2019 Series B 15 $79.5M Cowen Healthcare Investments
Perceptive Advisors
Sphera Funds
IMM Investment
QUAD Investment Management
UTC Investment
SV Investment Corp
MPM Capital
UBS Oncology Impact Fund
Deerfield Management
Arkin Bio Ventures
Celgene
Astellas Venture Management
Arkin Bio Ventures
Cowen Healthcare Investments
Perceptive Advisors
Celgene
Deerfield
Sphera Funds Management
Shinhan Private Equity
SV Investment Partners
UTC Investment Co.
Cowen Healthcare Investments
Perceptive Advisors
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research